-
- Désirée Larenas-Linnemann, Catalina Rincón-Pérez, Jorge A Luna-Pech, Alejandra Macías-Weinmann, Helena Vidaurri-de la Cruz, Elsy M Navarrete-Rodríguez, Blanca E Del Río-Navarro, Liliana Godínez-Alderete, Esther Guevara-Sanginés, José A Ortega-Martell, Mirna E Toledo-Bahena, Bárbara Elizondo-Villareal, Ileana M Madrigal-Beas, Mario Amaya-Guerra, José I Barreras-Salcedo, Leticia Boeta-Ángeles, Armando Campos-Rivera, Martha E Casillas-Guzmán, Mario R Duarte-Abdala, Sara E Espinosa-Padilla, Juan C García-Rodríguez, Minerva Gómez-Flores, Rubén A Gómez-Mendoza, Rosa Ma Del C Lacy-Niebla, Alessandra I Miranda-Aguirre, Claudia Olivares-Nolasco, Ernesto Onuma-Takane, Mariana Pérez-Luna, Carlos L Pliego-Reyes, Ma de Lourdes Rodríguez-Aguilera, María Del Mar Sáez-de Ocariz-Gutiérrez, Arturo Saucedo-Sánchez, Ana B Sotelo-Ocampo, Adriana Ma Valencia-Herrera, Jorge Vázquez-García, Guillermo H Wakida-Kuzunoki, Jacqueline Camarillo-Saavedra, and Fernanda A Rodríguez Monroy.
- Centro de Excelencia en Asma y Alergia, Médica Sur Fundación y Hospital, Ciudad de México, México.
- Gac Med Mex. 2023 Jan 20; 158 (Suplement 2): 11161-116.
AbstractWith the advancement of knowledge in relation to the physiopathogenesis of atopic dermatitis (AD), several new therapeutic forms have been developed. There are also new guidelines for self-care. On the other hand, there is still an underdiagnosis of AD in Mexico. Thus, the need was seen to develop a national guide, with a broad base among the different medical groups that care for patients with AD. The Atopic Dermatitis Guidelines for Mexico (GUIDAMEX) was developed with the ADAPTE methodology, with the endorsement and participation of ten national medical societies, from physicians in Primary Healthcare to allergists and dermatologists. Throughout the manuscript, key clinical questions are answered that lead to recommendations and suggestions for the diagnosis of AD (including differential diagnosis with immunodeficiency syndromes), the recognition of comorbidities and complications, non-pharmacological treatment including therapeutic education, treatment of flares and maintenance therapy. The latter encompasses general measures to avoid triggering factors, first-line treatment focussed on repair of the skin barrier, second-line treatment (topical proactive therapy), and third-line phototherapy or systemic treatment, including dupilumab and JAK inhibitors.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.